Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer’s disease

被引:0
作者
Sigrun Roeber
Felix Müller-Sarnowski
Julia Kress
Dieter Edbauer
Tanja Kuhlmann
Frank Tüttelmann
Christoph Schindler
Pia Winter
Thomas Arzberger
Ulrich Müller
Adrian Danek
Hans A. Kretzschmar
机构
[1] Ludwig-Maximilians-Universität München,Center for Neuropathology and Prion Research
[2] Ludwig-Maximilians-Universität München,Department of Neurology
[3] Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) e.V.- München,Institute of Human Genetics
[4] Justus-Liebig-Universität Giessen,Institute for Neuropathology
[5] Munich Cluster of Systems Neurology (SyNergy),Institute of Human Genetics
[6] University of Münster,undefined
[7] University of Münster,undefined
[8] Institute of Pathology,undefined
[9] Klinikum Nürnberg Nord,undefined
来源
Journal of Neural Transmission | 2015年 / 122卷
关键词
Autosomal dominant Alzheimer’s disease (ADAD); Early onset Alzheimer’s disease (EOAD); Presenilin; mutation; Spastic paraparesis; Alcoholism;
D O I
暂无
中图分类号
学科分类号
摘要
Presenilin 1(PSEN1) mutations are the major cause of autosomal dominant Alzheimer’s disease (ADAD). Here we report three novel PSEN1 mutations: Ile238_Lys239insIle, Ala246Pro and Ala164Val from patients who manifested in their twenties, forties and seventies, respectively, with variant clinical presentations of dementia. These cases exemplify the tremendous heterogeneity of clinical phenotypes and age of onset associated with PSEN1 mutations. The possibility of ADAD—not previously suspected in two of our patients—should always be considered in neurodegenerative conditions albeit they might neither exhibit the typical clinical picture of Alzheimer’s disease nor early onset dementia, which is regarded the primary clinical sign of hereditary neurodegeneration.
引用
收藏
页码:1715 / 1719
页数:4
相关论文
共 141 条
[1]  
Crook R(1998)A variant of Alzheimer’s disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 Nat Med 4 452-455
[2]  
Verkkoniemi A(1999)Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer’s disease by increased Abeta42 secretion Hum Mol Genet 8 1529-1540
[3]  
Perez-Tur J(2006)Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques Hum Mutat 27 1063-234
[4]  
Mehta N(2003)Molecular genetics of Alzheimer’s disease: presenilin 1 gene analysis in a cohort of patients from the Poznań region J Appl Genet 44 231-996
[5]  
Baker M(2010)A novel PSEN1 mutation (K239N) associated with Alzheimer’s disease with wide range age of onset and slow progression Eur J Neurol 17 994-840
[6]  
Houlden H(2014)Genetics of dementia Lancet 383 828-2175
[7]  
Farrer M(2001)Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer’s disease Am J Pathol 158 2165-482
[8]  
Hutton M(2004)Pathological and clinical heterogeneity of presenilin 1 gene mutations J Alzheimers Dis 6 475-292
[9]  
Lincoln S(2011)Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer’s disease due to a novel PSEN1 mutation Neurosci Lett 487 287-625
[10]  
Hardy J(2001)Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations Neurology 57 621-260